Advertisement
Canadian Journal of Cardiology

Erratum to “The Tale of Two Valves: Role of the Ross Procedure for Aortic Stenosis in Young Adults” [Can J Cardiol (2022):1469].

    Published:January 06, 2023DOI:https://doi.org/10.1016/j.cjca.2022.12.015
        Regarding “The Tale of Two Valves: Role of the Ross Procedure for Aortic Stenosis in Young Adults” by Chen et al., published in the September 2022 issue (Can J Cardiol 2022;38:1469): following the final acceptance of this paper, during the proof correction phase, the authors added 3 references that were not in the final approved article and that contravened journal guidelines for Letters to the Editor articles. Accordingly, the following 3 references are withdrawn from the article:
        • 1.
          Chen L, Salim Hammoud M, Jiang M, Bakir N, Karamlou T. Age- and sex-matched controls should not be the standard for the Ross procedure. JTCVS Open 2022. https://doi.org/10.1016/j.xjon.2022.05.015.
        • 2.
          Chen L, Salim Hammoud M, Mahboubi R, Karamlou T. Pulmonary conduit reoperation following the Ross procedure. Eur J Cardiothorac Surg 2022. https://doi.org/10.1093/ejcts/ezac267.
        • 3.
          Chen L, Salim Hammoud M, Ghandour H, Frankel WC, Karamlou T. Risk of endocarditis extension in Ross reintervention with transcatheter pulmonary valve replacement. J Am Coll Cardiol 2022;79:e457.
        The withdrawn references have been removed in the online version of the article.

        Linked Article

        • The Tale of Two Valves: Role of the Ross Procedure for Aortic Stenosis in Young Adults
          Canadian Journal of CardiologyVol. 38Issue 9
          • Preview
            In the June 2022 issue of the Canadian Journal of Cardiology, Rahmouni and colleagues reviewed management strategies for aortic stenosis in the low-risk patient.1 We commend the authors for their well-written overview. Although the treatment for aortic valve pathologies in older patients is more straightforward, the ideal treatment in younger low-risk patients remains a subject of debate. This subset of patients constitutes a clinical challenge owing to longer life expectancy and higher cumulative lifetime risk of prosthesis-related complications.
          • Full-Text
          • PDF